Hyperion Defi (HYPD) Operating Income (2017 - 2026)
Hyperion Defi (HYPD) posted quarterly Operating Income of $8.7 million for Q1 2026, up 388.12% year-over-year from $1.8 million in Q1 2025, and up 121.96% quarter-over-quarter from -$39.8 million in Q4 2025.
Hyperion Defi (HYPD) Operating Income (2017 - 2026) Analysis & Trends
Hyperion Defi (HYPD) has reported Operating Income for 10 consecutive years, with $8.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Income rose 388.12% year-over-year to $8.7 million; the TTM figure through Mar 2026 stood at -$35.0 million (up 15.77% YoY), while the FY2025 annual figure was -$46.7 million, up 4.14% from the prior year.
- Operating Income advanced to $8.7 million in Q1 2026 per HYPD's latest filing, from -$39.8 million in the prior quarter.
- Across five years, Operating Income topped out at $8.7 million in Q1 2026 and bottomed at -$39.8 million in Q4 2025.
- Historically, Operating Income has averaged -$8.2 million across 5 years, with a median of -$7.2 million in 2022.
- Annual changes were most pronounced in 2022 — Operating Income slumped 275.95% — and 2026, when it jumped 388.12%.
- Hyperion Defi's Operating Income stood at -$5.4 million in 2022, then slumped by 38.98% to -$7.5 million in 2023, then plunged by 160.51% to -$19.5 million in 2024, then plunged by 104.44% to -$39.8 million in 2025, then jumped by 121.96% to $8.7 million in 2026.
- Business Quant data shows HYPD's Operating Income at $8.7 million in Q1 2026, -$39.8 million in Q4 2025, and $4.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 231.44 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.55 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 133.12 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -375.75 Mn |
| 10 | Hyperion Defi | 44.65 Mn | 35.01 Mn | 357,693.00 | 31.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 31.01 Mn |
| Mar 31, 2026 | 8.73 Mn |
| Dec 31, 2025 | -39.77 Mn |
| Sep 30, 2025 | 4.43 Mn |
| Jun 30, 2025 | -8.35 Mn |
| Mar 31, 2025 | -3.03 Mn |
| Dec 31, 2024 | -19.45 Mn |
| Sep 30, 2024 | -7.33 Mn |
| Jun 30, 2024 | -11.69 Mn |
| Mar 31, 2024 | -10.27 Mn |
| Dec 31, 2023 | -7.47 Mn |
| Sep 30, 2023 | -6.52 Mn |
| Jun 30, 2023 | -5.96 Mn |
| Mar 31, 2023 | -5.46 Mn |
| Dec 31, 2022 | -5.37 Mn |
| Sep 30, 2022 | -7.23 Mn |
| Jun 30, 2022 | -7.12 Mn |
| Mar 31, 2022 | -7.19 Mn |
| Dec 31, 2021 | 3.05 Mn |
| Sep 30, 2021 | -5.93 Mn |